MSKCC Protocol
A five year female patient having Osteogenic Sarcoma was treated with MSKCC Protocol including –
high dose methotrexate and patient had a good response, tolerated the unventured Protocol well.
A five year female patient having Osteogenic Sarcoma was treated with MSKCC Protocol including –
high dose methotrexate and patient had a good response, tolerated the unventured Protocol well.